[go: up one dir, main page]

DZ2362A1 - Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline - Google Patents

Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline

Info

Publication number
DZ2362A1
DZ2362A1 DZ970212A DZ970212A DZ2362A1 DZ 2362 A1 DZ2362 A1 DZ 2362A1 DZ 970212 A DZ970212 A DZ 970212A DZ 970212 A DZ970212 A DZ 970212A DZ 2362 A1 DZ2362 A1 DZ 2362A1
Authority
DZ
Algeria
Prior art keywords
pharmaceutical compositions
compositions containing
indoline derivatives
sulfonyl
sulfonyl indoline
Prior art date
Application number
DZ970212A
Other languages
English (en)
Inventor
Jean-Claude Gautier
Simon John Fuller
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DZ2362A1 publication Critical patent/DZ2362A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DZ970212A 1996-12-05 1997-12-03 Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline DZ2362A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
DZ2362A1 true DZ2362A1 (fr) 2002-12-28

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ970212A DZ2362A1 (fr) 1996-12-05 1997-12-03 Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline

Country Status (25)

Country Link
EP (1) EP0941090A1 (fr)
JP (1) JP2000507618A (fr)
KR (1) KR20000069308A (fr)
CN (1) CN1239887A (fr)
AR (1) AR009651A1 (fr)
AU (1) AU716575B2 (fr)
BR (1) BR9712406A (fr)
CA (1) CA2273990A1 (fr)
CO (1) CO4910129A1 (fr)
DZ (1) DZ2362A1 (fr)
EE (1) EE9900206A (fr)
FR (1) FR2756736B1 (fr)
HU (1) HUP0001386A3 (fr)
ID (1) ID23373A (fr)
IL (1) IL129936A0 (fr)
IS (1) IS5062A (fr)
MY (1) MY132819A (fr)
NO (1) NO992724D0 (fr)
NZ (1) NZ335750A (fr)
RU (1) RU2174394C2 (fr)
SK (1) SK75599A3 (fr)
TR (1) TR199901702T2 (fr)
WO (1) WO1998024430A1 (fr)
YU (1) YU23099A (fr)
ZA (1) ZA9710919B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
WO2001034119A2 (fr) 1999-11-12 2001-05-17 Abbott Laboratories Inhibiteurs de cristallisation dans une dispersion solide
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
ID23373A (id) 2000-04-20
CO4910129A1 (es) 2000-04-24
RU2174394C2 (ru) 2001-10-10
BR9712406A (pt) 1999-08-31
EP0941090A1 (fr) 1999-09-15
YU23099A (en) 1999-11-22
JP2000507618A (ja) 2000-06-20
AU5326298A (en) 1998-06-29
CN1239887A (zh) 1999-12-29
AU716575B2 (en) 2000-03-02
KR20000069308A (ko) 2000-11-25
SK75599A3 (en) 2000-08-14
AR009651A1 (es) 2000-04-26
ZA9710919B (en) 1999-06-04
HUP0001386A2 (hu) 2001-04-28
IS5062A (is) 1999-06-01
EE9900206A (et) 1999-12-15
NO992724L (no) 1999-06-04
HUP0001386A3 (en) 2002-03-28
NO992724D0 (no) 1999-06-04
WO1998024430A1 (fr) 1998-06-11
NZ335750A (en) 2001-06-29
CA2273990A1 (fr) 1998-06-11
FR2756736B1 (fr) 1999-03-05
TR199901702T2 (en) 1999-09-21
MY132819A (en) 2007-10-31
IL129936A0 (en) 2000-02-29
FR2756736A1 (fr) 1998-06-12

Similar Documents

Publication Publication Date Title
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DK0747050T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan
DZ2361A1 (fr) Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
ID22973A (id) Komposisi farmasi dari pemberian oral dari turunan n-piperidino-3-pirazolkarboksamida, garam-garam dan solvatnya
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DK0936913T3 (da) Oralt farmaceutisk præparat indeholdende ibandronat
PT1066027E (pt) Composicao farmaceutica de topiramato
ID18663A (id) Komposisi farmasi berlapis enterik
MA24466A1 (fr) Compositions contenant de la tetrahydrolistatine
IL120699A0 (en) Indole derivatives and pharmaceutical compositions containing them
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
IS5317A (is) Föst lyfjasamsetning sem inniheldur bensófúran afleiður
MA26507A1 (fr) Compositions pharmaceutiques d'aerosol
BR9604951A (pt) Composição farmacêutica contendo derivados den n-fosfonoglicina par inibir o desenvolvimento de viroses e cânceres
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
HUP0002324A3 (en) Benzimidazole derivatives and pharmaceutical compositions containing them
FI962969A (fi) Indolijohdannaisia 5-HT1:n agonisteina
DZ2362A1 (fr) Compositions pharmaceutiques contenant des dérivésde n-sulfonyl indoline
IL118424A0 (en) Pharmaceutical compositions containing benzimidazole derivative
EE9800400A (et) Diklofenaaki sisaldavad farmatseutilised kompositsioonid
IS2515B (is) Lyfjasamsetningar
PT941100E (pt) Composicoes farmaceuticas